Literature DB >> 12435836

Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Antonio L Estrada1.   

Abstract

OBJECTIVE: This article reviews the literature on the impact of HIV/AIDS, hepatitis B and C viruses (HBV, HCV), and tuberculosis on minority drug injectors in the United States. OBSERVATIONS: Injection drug use is a key factor in the transmission of blood-borne pathogens, and HIV disease is exacerbated by tuberculosis infection. Minority drug injectors are disproportionately represented in the national statistics on these infections. Behavioral epidemiologic studies show that both injection-related risk factors years of injecting drugs, type of drug injected, direct and indirect sharing of injection paraphernalia) and sex-related risk factors (lack of condom use, multiple sexual partners, survival sex) are conducive to the spread of HIV, HBV, and HCV.
CONCLUSIONS: Two issues must be addressed to halt the spread of HIV infection and hepatitis B and C. The capacity of syringe-exchange programs to refer participants to drug treatment programs and facilitate access to health and social services must be increased. Culturally appropriate behavioral interventions targeting risk behaviors among ethnic and racial minorities, especially women, must be developed and put in place.

Entities:  

Mesh:

Year:  2002        PMID: 12435836      PMCID: PMC1913689     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  44 in total

1.  Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program.

Authors:  N Salomon; D C Perlman; P Friedmann; V Ziluck; D C Des Jarlais
Journal:  Int J Tuberc Lung Dis       Date:  2000-01       Impact factor: 2.373

2.  Drug use and HIV risks among African-American, Mexican-American, and Puerto Rican drug injectors.

Authors:  A L Estrada
Journal:  J Psychoactive Drugs       Date:  1998 Jul-Sep

3.  Differential survival in blacks and Hispanics with AIDS.

Authors:  M Murrain
Journal:  Ethn Health       Date:  1996-12       Impact factor: 2.772

4.  Two-step tuberculin skin testing of injection drug users recruited from community-based settings.

Authors:  A R Lifson; S M Grant; J Lorvick; F D Pinto; H He; S Thompson; E G Keudell; M J Stark; R E Booth; J K Watters
Journal:  Int J Tuberc Lung Dis       Date:  1997-04       Impact factor: 2.373

5.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors:  R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

6.  Prevalence of Mycobacterium tuberculosis infection among injection drug users in Toronto.

Authors:  I D Rusen; L Yuan; M E Millson
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

7.  Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis.

Authors:  C R Friedman; G C Quinn; B N Kreiswirth; D C Perlman; N Salomon; N Schluger; M Lutfey; J Berger; N Poltoratskaia; L W Riley
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

8.  Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy.

Authors:  C L Daley; J A Hahn; A R Moss; P C Hopewell; G F Schecter
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 21.405

9.  Needle-exchange attendance and health care utilization promote entry into detoxification.

Authors:  S A Strathdee; D D Celentano; N Shah; C Lyles; V A Stambolis; G Macalino; K Nelson; D Vlahov
Journal:  J Urban Health       Date:  1999-12       Impact factor: 3.671

Review 10.  The role of needle exchange programs in HIV prevention.

Authors:  D Vlahov; B Junge
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

View more
  15 in total

Review 1.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

2.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

3.  Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus; Eszter Ujhelyi
Journal:  Eur J Public Health       Date:  2009-02-17       Impact factor: 3.367

4.  The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland.

Authors:  Karin Elizabeth Tobin; Satoko Janet Kuramoto; Melissa Ann Davey-Rothwell; Carl Asher Latkin
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

Review 5.  Chronic liver disease in the Hispanic population of the United States.

Authors:  Andres F Carrion; Ravi Ghanta; Olveen Carrasquillo; Paul Martin
Journal:  Clin Gastroenterol Hepatol       Date:  2011-05-12       Impact factor: 11.382

6.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

7.  Injecting drug use is associated with HIV risk perception among Mexican Americans in the Rio Grande Valley of South Texas, USA.

Authors:  E J Essien; G O Ogungbade; D Ward; M E Fernandez-Esquer; C R Smith; L Holmes
Journal:  Public Health       Date:  2007-10-24       Impact factor: 2.427

8.  Methamphetamine and HIV-Tat alter murine cardiac DNA methylation and gene expression.

Authors:  Christopher A Koczor; Earl Fields; Mark J Jedrzejczak; Zhe Jiao; Tomika Ludaway; Rodney Russ; Joan Shang; Rebecca A Torres; William Lewis
Journal:  Toxicol Appl Pharmacol       Date:  2015-08-22       Impact factor: 4.219

9.  Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities.

Authors:  Nickolas D Zaller; Alexander R Bazazi; Lavinia Velazquez; Josiah D Rich
Journal:  Int J Environ Res Public Health       Date:  2009-02-23       Impact factor: 3.390

10.  Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.

Authors:  Christine U Oramasionwu; Jonathan M Hunter; Jeff Skinner; Laurajo Ryan; Kenneth A Lawson; Carolyn M Brown; Brittany R Makos; Christopher R Frei
Journal:  BMC Infect Dis       Date:  2009-08-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.